S100鈣結合蛋白A6(S100A6)多克隆抗體(生物素標記)
Biotin-Linked Polyclonal Antibody to S100 Calcium Binding Protein A6 (S100A6)
S100-A6; 2A9; 5B10; CABP; CACY; PRA; MLN 4; Calcyclin; Growth factor-inducible protein 2A9; Prolactin receptor-associated protein
- 編號LAB769Ra71
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源抗體標記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物生物素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 601 ¥ 1403 ¥ 2004 ¥ 5010 ¥ 20040
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P;
Samples: Rat Placenta Tissue
Primary Ab: 20μg/ml Biotin-Linked Polyclonal Antibody to S100 Calcium Binding Protein A6 (S100A6)
Second Ab: 2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對S100A6的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別S100A6。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學：5-20μg/mL;1:25-100
免疫細胞化學：5-20μg/mL;1:25-100
最佳稀釋倍數最終由用戶決定。
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB769Ra01 | S100鈣結合蛋白A6(S100A6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB769Ra01 | S100鈣結合蛋白A6(S100A6)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB769Ra71 | S100鈣結合蛋白A6(S100A6)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAB769Ra21 | S100鈣結合蛋白A6(S100A6)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB769Ra | S100鈣結合蛋白A6(S100A6)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB769Ra | S100鈣結合蛋白A6(S100A6)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| KSB769Ra01 | S100鈣結合蛋白A6(S100A6)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Proteomics | Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction [PubMed: 23201116] |
| Tumour Biol | Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer [PubMed: 26361956] |
| Clinical and Translational Medicine | Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma [pubmed:27709523] |
| Gastroenterology | Tu1938-Micronutrients Assessment in Patients with Cirrhosis [10.1016:S0016-5085(18)33544-3] |
| Gastroenterology | Tu1942-PI3K/AKT-Mediated Upregulation of C7 Inhibits Colorectal Cancer Proliferation and Metastasis [10.1016:S0016-5085(18)33544-5] |
| Tumor?Biology | Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma [Pubmed:29629840] |
| scandinavian journal of clinical & laboratory investigation | Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study [Pubmed: 31856598] |
| CELL BIOCHEMISTRY AND FUNCTION | S100A6 represses Calu?\6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis [34008212] |
| MOLECULAR VISION | Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays [34012227] |
留言咨詢
